241 related articles for article (PubMed ID: 33551821)
1. Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway
Li T; Fang T; Xu L; Liu X; Li X; Xue M; Yu X; Sun B; Chen L
Front Pharmacol; 2020; 11():622153. PubMed ID: 33551821
[No Abstract] [Full Text] [Related]
2. Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway.
Yu X; Meng Z; Fang T; Liu X; Cheng Y; Xu L; Liu X; Li X; Xue M; Li T; Sun B; Chen L
Front Physiol; 2022; 13():817542. PubMed ID: 35299662
[TBL] [Abstract][Full Text] [Related]
3. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
4. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium-glucose cotransporter 2 inhibitor, empagliflozin, and α-glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes.
Kim JW; Lee YJ; You YH; Moon MK; Yoon KH; Ahn YB; Ko SH
J Cell Biochem; 2019 May; 120(5):8534-8546. PubMed ID: 30474134
[TBL] [Abstract][Full Text] [Related]
6. C1q/TNF-Related Protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress.
Jung TW; Hong HC; Hwang HJ; Yoo HJ; Baik SH; Choi KM
Mol Cell Endocrinol; 2015 Dec; 417():131-40. PubMed ID: 26419929
[TBL] [Abstract][Full Text] [Related]
7.
Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635
[No Abstract] [Full Text] [Related]
8. Interleukin-38 alleviates hepatic steatosis through AMPK/autophagy-mediated suppression of endoplasmic reticulum stress in obesity models.
Sun JL; Cho W; Oh H; Abd El-Aty AM; Hong SA; Jeong JH; Jung TW
J Cell Physiol; 2024 Apr; 239(4):e31184. PubMed ID: 38197464
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT
Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029
[TBL] [Abstract][Full Text] [Related]
10. Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway.
Li L; Li Q; Huang W; Han Y; Tan H; An M; Xiang Q; Zhou R; Yang L; Cheng Y
Front Pharmacol; 2021; 12():589273. PubMed ID: 34093169
[TBL] [Abstract][Full Text] [Related]
11. Micheliolide alleviates hepatic steatosis in db/db mice by inhibiting inflammation and promoting autophagy via PPAR-γ-mediated NF-кB and AMPK/mTOR signaling.
Zhong J; Gong W; Chen J; Qing Y; Wu S; Li H; Huang C; Chen Y; Wang Y; Xu Z; Liu W; Li H; Long H
Int Immunopharmacol; 2018 Jun; 59():197-208. PubMed ID: 29656210
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell-derived exosomes exert ameliorative effects in type 2 diabetes by improving hepatic glucose and lipid metabolism via enhancing autophagy.
He Q; Wang L; Zhao R; Yan F; Sha S; Cui C; Song J; Hu H; Guo X; Yang M; Cui Y; Sun Y; Sun Z; Liu F; Dong M; Hou X; Chen L
Stem Cell Res Ther; 2020 Jun; 11(1):223. PubMed ID: 32513303
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg1 Ameliorates Palmitic Acid-Induced Hepatic Steatosis and Inflammation in HepG2 Cells via the AMPK/NF-
Xiao Q; Zhang S; Yang C; Du R; Zhao J; Li J; Xu Y; Qin Y; Gao Y; Huang W
Int J Endocrinol; 2019; 2019():7514802. PubMed ID: 31467529
[TBL] [Abstract][Full Text] [Related]
14. Tangshen Formula Alleviates Hepatic Steatosis by Inducing Autophagy Through the AMPK/SIRT1 Pathway.
Wang Y; Zhao H; Li X; Li N; Wang Q; Liu Y; Liang Q; Shao Z; Zhang N; Zhao T; Peng L; Li P
Front Physiol; 2019; 10():494. PubMed ID: 31105592
[TBL] [Abstract][Full Text] [Related]
15. Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-γ, AMPK/Akt/mTOR signaling and autophagy.
Zhong J; Gong W; Lu L; Chen J; Lu Z; Li H; Liu W; Liu Y; Wang M; Hu R; Long H; Wei L
Int Immunopharmacol; 2017 Jan; 42():176-184. PubMed ID: 27919004
[TBL] [Abstract][Full Text] [Related]
16. Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models.
Kim DY; Chung KS; Park JY; Gee HY
Biomed Pharmacother; 2023 May; 161():114445. PubMed ID: 36842353
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK.
Huang Q; Wang T; Yang L; Wang HY
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534819
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway.
Fang Y; Ji L; Zhu C; Xiao Y; Zhang J; Lu J; Yin J; Wei L
Front Cell Dev Biol; 2020; 8():602574. PubMed ID: 33330497
[TBL] [Abstract][Full Text] [Related]
19. Jinlida granule inhibits palmitic acid induced-intracellular lipid accumulation and enhances autophagy in NIT-1 pancreatic β cells through AMPK activation.
Wang D; Tian M; Qi Y; Chen G; Xu L; Zou X; Wang K; Dong H; Lu F
J Ethnopharmacol; 2015 Feb; 161():99-107. PubMed ID: 25510732
[TBL] [Abstract][Full Text] [Related]
20. SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in
Korbut AI; Taskaeva IS; Bgatova NP; Muraleva NA; Orlov NB; Dashkin MV; Khotskina AS; Zavyalov EL; Konenkov VI; Klein T; Klimontov VV
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
